Doctors and pharmaceutical companies on Thursday questioned calls by MPs for fresh measures to limit drug marketing and boost the prescription of generic medicines in the UK.

The British Medical Association (BMA) said there were good reasons for periodically prescribing branded drugs even after patents had expired. It also queried the power of drug company marketing to GPs.